Review

. 2018 Sep 14;23(9):2357.

doi: 10.3390/molecules23092357.

Effects of Tea Catechins on Alzheimer's Disease: Recent Updates and Perspectives

Kazuki Ide^{1

2

3}, Norihiro Matsuoka⁴, Hiroshi Yamada⁵, Daisuke Furushima⁶, Koji Kawakami^{7

8}

Affiliations

¹ Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto 606-8501, Japan. ide.kazuki.2r@kyoto-u.ac.jp.
² Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Kyoto 606-8501, Japan. ide.kazuki.2r@kyoto-u.ac.jp.
³ Department of Drug Evaluation and Informatics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan. ide.kazuki.2r@kyoto-u.ac.jp.
⁴ Jyoto Hospital, 11-22 Hanatenhigashi 2-chome, Tsurumi-ku Osaka-shi, Osaka 538-0044, Japan. kyotomatsu@hotmail.com.
⁵ Department of Drug Evaluation and Informatics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan. hyamada@u-shizuoka-ken.ac.jp.
⁶ Department of Drug Evaluation and Informatics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan. dfuru@u-shizuoka-ken.ac.jp.
⁷ Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto 606-8501, Japan. kawakami.koji.4e@kyoto-u.ac.jp.
⁸ Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Kyoto 606-8501, Japan. kawakami.koji.4e@kyoto-u.ac.jp.

PMID: 30223480
PMCID: PMC6225145
DOI: 10.3390/molecules23092357

Review

Effects of Tea Catechins on Alzheimer's Disease: Recent Updates and Perspectives

Kazuki Ide et al. Molecules. 2018.

. 2018 Sep 14;23(9):2357.

doi: 10.3390/molecules23092357.

Authors

Kazuki Ide^{1

2

3}, Norihiro Matsuoka⁴, Hiroshi Yamada⁵, Daisuke Furushima⁶, Koji Kawakami^{7

8}

Affiliations

¹ Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto 606-8501, Japan. ide.kazuki.2r@kyoto-u.ac.jp.
² Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Kyoto 606-8501, Japan. ide.kazuki.2r@kyoto-u.ac.jp.
³ Department of Drug Evaluation and Informatics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan. ide.kazuki.2r@kyoto-u.ac.jp.
⁴ Jyoto Hospital, 11-22 Hanatenhigashi 2-chome, Tsurumi-ku Osaka-shi, Osaka 538-0044, Japan. kyotomatsu@hotmail.com.
⁵ Department of Drug Evaluation and Informatics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan. hyamada@u-shizuoka-ken.ac.jp.
⁶ Department of Drug Evaluation and Informatics, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, Japan. dfuru@u-shizuoka-ken.ac.jp.
⁷ Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto 606-8501, Japan. kawakami.koji.4e@kyoto-u.ac.jp.
⁸ Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Kyoto 606-8501, Japan. kawakami.koji.4e@kyoto-u.ac.jp.

PMID: 30223480
PMCID: PMC6225145
DOI: 10.3390/molecules23092357

Abstract

Alzheimer's disease (AD) is one of the most common neurodegenerative disorders worldwide. Its incidence is gradually increasing because of an aging demographic. Therefore, AD prevention and modification is important to improve the health status of older adults. Oxidative stress is a component of the pathological mechanisms underlying AD. It is caused by a disruption of the balance between reactive oxygen species and antioxidant molecules. This imbalance also causes neuroinflammation. Catechins, which are bioactive components of tea, have antioxidative and anti-inflammatory effects. Moreover, other potential properties related to AD prevention and modification have been reported in in vitro and in vivo studies. Several clinical studies have also been conducted to date. The current review summarizes recent updates and perspectives of the effects of catechins on AD based on the molecular mechanisms and related clinical studies.

Keywords: Alzheimer’s disease; catechin; clinical study; molecular mechanisms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

**Figure 1**
Chemical structures of several catechins.

See this image and copyright information in PMC

Cited by

Modulating Inflammation-Mediated Diseases via Natural Phenolic Compounds Loaded in Nanocarrier Systems.
Rakotondrabe TF, Fan MX, Muema FW, Guo MQ. Rakotondrabe TF, et al. Pharmaceutics. 2023 Feb 19;15(2):699. doi: 10.3390/pharmaceutics15020699. Pharmaceutics. 2023. PMID: 36840021 Free PMC article. Review.
PPAR and functional foods: Rationale for natural neurosteroid-based interventions for postpartum depression.
Matrisciano F, Pinna G. Matrisciano F, et al. Neurobiol Stress. 2020 Apr 19;12:100222. doi: 10.1016/j.ynstr.2020.100222. eCollection 2020 May. Neurobiol Stress. 2020. PMID: 32426424 Free PMC article.
Comprehensive Insights into Pathophysiology of Alzheimer's Disease: Herbal Approaches for Mitigating Neurodegeneration.
Sen D, Rathee S, Pandey V, Jain SK, Patil UK. Sen D, et al. Curr Alzheimer Res. 2024;21(9):625-648. doi: 10.2174/0115672050309057240404075003. Curr Alzheimer Res. 2024. PMID: 38623983 Review.
Natural Compounds for Preventing Age-Related Diseases and Cancers.
Ki MR, Youn S, Kim DH, Pack SP. Ki MR, et al. Int J Mol Sci. 2024 Jul 9;25(14):7530. doi: 10.3390/ijms25147530. Int J Mol Sci. 2024. PMID: 39062777 Free PMC article. Review.
Tieguanyin Oolong Tea Extracts Alleviate Behavioral Abnormalities by Modulating Neuroinflammation in APP/PS1 Mouse Model of Alzheimer's Disease.
Kang H, Zhou H, Ye Y, Yang J, Liu Z, He P, Li B, Wu Y, Wang Y, Tu Y. Kang H, et al. Foods. 2021 Dec 29;11(1):81. doi: 10.3390/foods11010081. Foods. 2021. PMID: 35010207 Free PMC article.

See all "Cited by" articles

References

1. Karlawish J., Jack C.R., Jr., Rocca W.A., Snyder H.M., Carrillo M.C. Alzheimer’s disease: The next frontier-Special Report 2017. Alzheimers Dement. 2017;13:374–380. doi: 10.1016/j.jalz.2017.02.006. - DOI - PubMed
1. Small D.H., Cappai R. Alois Alzheimer and Alzheimer’s disease: A centennial perspective. J. Neurochem. 2006;99:708–710. doi: 10.1111/j.1471-4159.2006.04212.x. - DOI - PubMed
1. Hippius H., Müller N. The work of Emil Kraepelin and his research group in München. Eur. Arch. Psychiatry Clin. Neurosci. 2008;258:3–11. doi: 10.1007/s00406-008-2001-6. - DOI - PubMed
1. Maurer K., Volk S., Gerbaldo H. Auguste D and Alzheimer’s disease. Lancet. 1997;349:1546–1549. doi: 10.1016/S0140-6736(96)10203-8. - DOI - PubMed
1. Alzheimer’s Association 2017 Alzheimer’s disease facts and figures. Alzheimers Dement. 2017;13:325–373. doi: 10.1016/j.jalz.2017.02.001. - DOI

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Effects of Tea Catechins on Alzheimer's Disease: Recent Updates and Perspectives

Affiliations

Effects of Tea Catechins on Alzheimer's Disease: Recent Updates and Perspectives

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical